XPOVIO WITH DEXAMETHASONE APPROVED FOR REFRACTORY MULTIPLE MYELOMA.
Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma, the U.S. Food and Drug Administration announced last week. The drug combination was granted accelerated approval for patients whose disease remains resistant to other treatments, including at least two proteasome inhibitors, at least two immunomodulatory […]
XPOVIO WITH DEXAMETHASONE APPROVED FOR REFRACTORY MULTIPLE MYELOMA. Read More »
